← Open Payments lookup

ANANDKUMAR PANCHAL: Open Payments

NPI 1629453303 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,229 in 23 payments from 8 companies in 2025. Trend: 2023 $1,069 · 2024 $2,225 · 2025 $2,229

Food & beverage: $2,229
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$504
Teva Pharmaceuticals USA, Inc.3$373
Janssen Pharmaceuticals, Inc3$285
Otsuka America Pharmaceutical, Inc.2$238
Alkermes, Inc.3$222
Axsome Therapeutics, Inc.2$220
ABBVIE INC.2$212
Neurocrine BioSciences, Inc.4$176

Products named: CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, Auvelity, VRAYLAR, INGREZZA, UZEDY, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.